Učitavanje...
Mutational spectrum and classification of novel mutations in patients with metastatic gastrointestinal stromal tumours
In total, ~85% of malignant gastrointestinal stromal tumours (GISTs) harbour activating mutations in one of the genes KIT or PDGFRA, while 10-15% of all GISTs have no detectable KIT or PDGFRA mutations, but could have alterations in genes of the succinate dehydrogenase complex or in BRAF, PIK3CA or...
Spremljeno u:
| Izdano u: | Int J Oncol |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
D.A. Spandidos
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7170035/ https://ncbi.nlm.nih.gov/pubmed/32236636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2020.5028 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|